Vivostat A/S

Vivostat® develop, manufacture and market the Vivostat® system, which is sold through direct sales channels and distributors throughout Europe, Asia and the Middle East.

The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) to prevent/stop bleeding or stimulate the healing of chronic wounds. With the Vivostat® system It is also possible to co-deliver a desired antibiotic with Vivostat® Fibrin Sealant or Vivostat PRF®.

The fully automated Vivostat® system consists of three components:

1. The Processor Unit
The Processor Unit is used to process the patient’s blood and prepare the Vivostat® Fibrin Sealant or Vivostat PRF® solution.

2. The Applicator Unit
The Applicator Unit controls the delivery of the Vivostat® solution to the site of treatment.

3. The Disposable Set
The single-use set contains all components needed for preparation and application of Vivostat® Fibrin Sealant or Vivostat PRF®. It is available with a range of application devices each optimised for different types of applications.

The Vivostat® system can be used in many clinical applications including but not limited to; cardiac, thoracic, orthopedic and neurosurgery as well as in wound healing treatment.

For more information on the Vivostat® system visit the company website at: http://www.vivostat.com/products

For questions or inquiries contact Vivostat by e-mail at: [email protected]

If you want to be a distributor please go to http://www.vivostat.com/your-contact and find a contact in your area

Company’s Keywords:

fibrin, prf, autologous, wound, wound care, platelets, platelet rich fibrin, diabetic wounds, coapplication, abdominal surgery, urology, air leakages, sealing, medical devices, tissue regeneration, codelivery, vivostat, neurosurgery, cardiac surgery, fistula, burns